Huang M, Lindahl R
Department of Biochemistry and Molecular Biology, University of South Dakota, School of Medicine, Vermillion 57069.
Carcinogenesis. 1990 Jul;11(7):1059-65. doi: 10.1093/carcin/11.7.1059.
The effects of certain in vivo inducers of tumor-associated aldehyde dehydrogenase (aldehyde:NAD+ oxidoreductase, EC 1.2.1.3; ALDH) activity on the expression of tumor-associated ALDH (T-ALDH) in vitro have been investigated using cultured rat hepatocytes and hepatoma cell lines. Two distinct groups of T-ALDH inducers have been identified. Three hepatocarcinogenic initiators 2-acetylaminofluorene, diethylnitrosamine and ethionine, which cause changes in T-ALDH in vivo, do not induce T-ALDH activity in cultured rat hepatocytes or hepatoma cell lines following either short-term or long-term exposures. In contrast, polycyclic aromatic hydrocarbons, such as 3-methylcholanthrene, benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene, induce an immediate increase of T-ALDH activity in both cultured rat hepatocytes and hepatoma cell lines. Synthesis and degradation rates of T-ALDH mRNA and protein have also been determined. The synthesis of T-ALDH protein is coupled with the increased synthesis of T-ALDH mRNA when the T-ALDH gene is constitutively expressed or activated by an inducer. Both T-ALDH mRNA (t1/2 = 25 - 34 h) and protein (t1/2 = 88 - 95 h) in high T-ALDH activity cell lines or low-activity cell lines treated with an inducer are relatively stable. Combined with previous studies, the results suggest that at least two different mechanisms are involved in T-ALDH gene expression; events occurring during initiation as well as during promotion appear to be involved in the genetically stable changes in T-ALDH gene expression which occur in vivo. The results also indicate that the lack of T-ALDH activity in normal hepatocytes or low-activity hepatoma cell lines is due to repression of the T-ALDH gene rather than to the differential stability of T-ALDH mRNA or protein.
利用培养的大鼠肝细胞和肝癌细胞系,研究了某些体内肿瘤相关醛脱氢酶(醛:NAD⁺氧化还原酶,EC 1.2.1.3;ALDH)活性诱导剂对体外肿瘤相关ALDH(T-ALDH)表达的影响。已鉴定出两类不同的T-ALDH诱导剂。三种致癌起始剂2-乙酰氨基芴、二乙基亚硝胺和乙硫氨酸,它们在体内会引起T-ALDH的变化,但在短期或长期暴露后,均不能在培养的大鼠肝细胞或肝癌细胞系中诱导T-ALDH活性。相反,多环芳烃,如3-甲基胆蒽、苯并[a]芘和7,12-二甲基苯并[a]蒽,可在培养的大鼠肝细胞和肝癌细胞系中立即诱导T-ALDH活性增加。还测定了T-ALDH mRNA和蛋白质的合成及降解速率。当T-ALDH基因组成性表达或被诱导剂激活时,T-ALDH蛋白质的合成与T-ALDH mRNA合成的增加相关联。用诱导剂处理的高T-ALDH活性细胞系或低活性细胞系中的T-ALDH mRNA(半衰期=25 - 34小时)和蛋白质(半衰期=88 - 95小时)都相对稳定。结合先前的研究结果表明,T-ALDH基因表达至少涉及两种不同机制;启动期和促癌期发生的事件似乎都参与了体内T-ALDH基因表达的遗传稳定变化。结果还表明,正常肝细胞或低活性肝癌细胞系中T-ALDH活性的缺乏是由于T-ALDH基因的抑制,而非T-ALDH mRNA或蛋白质的差异稳定性所致。